Detalhe da pesquisa
1.
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
Lancet Oncol
; 24(5): 553-562, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011650
2.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Cancer
; 128(5): 966-974, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784056
3.
Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review.
J Natl Compr Canc Netw
; 20(4): 406-416.e11, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390767
4.
Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot study.
Support Care Cancer
; 30(5): 3829-3838, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034197
5.
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentary.
Future Oncol
; 17(4): 363-369, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397134
6.
Gene fusion analysis in renal cell carcinoma by FusionPlex RNA-sequencing and correlations of molecular findings with clinicopathological features.
Genes Chromosomes Cancer
; 59(1): 40-49, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31400230
7.
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
Cancer
; 126(18): 4156-4167, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673417
8.
Abundant CD8+ tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma.
Ann Diagn Pathol
; 47: 151537, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32454441
9.
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Lancet Oncol
; 20(10): 1370-1385, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427204
10.
Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
Cancer Immunol Immunother
; 68(12): 1979-1993, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31686124
11.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 373(19): 1803-13, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406148
12.
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
N Engl J Med
; 366(26): 2455-65, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22658128
13.
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.
Blood
; 122(8): 1341-9, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23741009
14.
Systemic therapy of metastatic melanoma: on the road to cure.
Oncology (Williston Park)
; 29(2): 126-35, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683834
15.
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.
J Immunol
; 191(4): 1567-77, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23851683
16.
Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors.
Front Cell Dev Biol
; 12: 1387198, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726320
17.
Telemedicine for Multidisciplinary Urologic Cancer Care: A Prospective Single Institution Study.
Clin Genitourin Cancer
; 22(3): 102058, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537419
18.
Immunohistochemical Detection of 5T4 in Renal Cell Carcinoma.
Appl Immunohistochem Mol Morphol
; 31(3): 135-144, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735485
19.
CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review.
Bone Marrow Transplant
; 58(4): 353-359, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575360
20.
Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system.
Neoplasia
; 46: 100948, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944353